stella
beta
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1 — Stella
Recruiting
Back to AML trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Blood Diseases Hospital, Tianjin, Tianjin Municipality
View full record on ClinicalTrials.gov